Identification of a putative motif for binding of peptides to HLA-DQ2

International Immunology

Volumn 8, Issue 2, 1996, Pages 177-182

  Johansen, Bente H ^a   Vartdal, Frode ^a   Eriksen, Jon Amund ^b   Thorsby, Erik ^a   Sollid, Ludvig M ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b STATOIL   (Norway)

Author keywords

Anchors; Celiac disease; Peptide binding

Indexed keywords

HLA DQ ANTIGEN; PEPTIDE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELIAC DISEASE; DELETION MUTANT; HUMAN; HUMAN CELL; HYDROPHOBICITY; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

AMINO ACIDS; HLA-DQ ANTIGENS; HUMANS; OVALBUMIN; PEPTIDE FRAGMENTS; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030050786     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.2.177     Document Type: Article

References (32)

1. Shimonkevitz, R., Colon, S., Kappler, J. W , Marrack, P. and Grey, H. M. 1984. Antigen recognition by H-2-restricted T cells II A tryptic ovalbumin peptide that substitutes for processed antigen. J. Immunol. 133:2067.
2. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287.
3. Brown, J. H., Jardetzky T. S., Gorga, J. C , Stern, L. J., Urban, R. G, Strominger, J. L and Wiley, D C 1993 Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
4. Stern, L J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G , Strominger, J. L and Wiley D. C 1994 Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide Nature 368 215
5. Brown, J. H., Jardetzky, T., Saper, M. A., Samraoui, B., Bjorkman, P J. and Wiley, D C. 1988. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules Nature 332:845.
6. Rammensee, H G., Friede, T and Stevanovic, S. 1995. MHC ligands and peptide motifs: first listing Immunogenetics 41.178.
7. Falk, K , Rötzschke, O., Stevanovic, S., Jung, G and Rammensee, H G. 1994. Pool sequencing of natural HLA-DR, DQ and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 39 230.
8. Sidney, J , Oseroff, C , del Guercio, M. F , Southwood, S , Krieger, J I , Ishioka, G. Y., Sakaguchi, K , Appella, E. and Sette, A. 1994. Definition of a DQ3.1-specific binding motif. J. Immunol. 152: 4516
9. Chicz, R. M., Lane, W S., Robinson, R. A., Trucco, M., Strominger, J. L and Gorga, J. C., 1994. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8 Int Immunol 6:1639.
10. Verreck, F. A. W., van de Poel, A., Termijtelen A , Amons, R., Drijfhout, J. W and Koning, F. 1994. Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing Eur J. Immunol. 24:375.
11. Sollid, L. M., Markussen, G, Ek, J., Gjerde, H., Vartdal, F. and Thorsby, E. 1989 Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer J. Exp. Med. 169:345.
12. β contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599
13. Thorsby, E and Rønningen, K. S. 1993. Particular HLA-DQ molecules play a dominant role in determing susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:371
14. Johansen, B H., Buus, S , Vartdal, F., Viken, H , Eriksen, J. A , Thorsby, E. and Sollid, L. M. 1994 Binding of peptides to HLA-DQ molecules. peptide binding properties of the disease-associated HLA-DQ(α1*0501, β1*0201) molecule Int. Immunol. 6.453
15. Buus, S , Sette, A., Colon, S. M , Jenis D. M. and Grey, H M. 1986. Isolation and characterization of antigen-la complexes involved in T cell recognition. Cell 47:1071
16. Gorga, J. C , Horejsi V., Johnson D. R., Raghupathy, R and Strominger, J. L 1987. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line J Biol Chem. 262:16087
17. Viken, H. D., Paulsen, G., Sollid, L M , Lundin, K. E. A., Tjønnfjord, G. E., Thorsby, E. and Gaudernack, G. 1995 Characterization of an HLA-DQ2 specific monoclonal antibody. Influence of amino acid substitutions in DQβ1*0202 Human Immunol 42 319.
18. Schneider, C , Newman R A., Sutherland, D. R , Asser, U and Greaves, M. F 1982. A one-step purification of membrane proteins using a high efficiency immunomatrix. J. Biol Chem. 257 10766
19. 131 I-labelled human growth hormone of high specific radioactivity. Biochem. J. 89:114.
20. Buus, S , Stryhn, A, Winther, K., Kirkeby, N. and Pedersen, L Ø. 1995. Receptor-ligand interactions measured by an improved spun column chromatography technique. A high efficiency and high throughput size separation method Biochim. Biophys. Acta 1243:453
21. Cantor, C. and Schimmel, P 1980 Biophysical Chemistry Part 1. The Conformation of Biological Macromolecules. p. 258. W H. Freeman, San Francisco.
22. Malcherek, G., Gnau, V , Stevanovic, S., Rammensee, H. G., Jung, G and Melms A 1994 Analysis of allele-specific contact sites of natural HLA-DR17 ligands. J. Immunol. 153:1141.
23. Jardetzky, T S., Gorga, J. C., Busch, R., Rothbard, J., Strominger, J. L. and Wiley D. C., 1990. Peptide binding to HLA-DR1. a peptide with most residues substituted to alanine retains MHC binding. EMBO J. 9:1797
24. Hill, C M , Liu, A., Marshall, K. W., Mayer, J., Jorgensen, B , Yuan, B., Cubbon, R M , Nichols, E. A , Wicker, L. S. and Rothbard, J B. 1994, Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J. Immunol. 152: 2890
25. Rammensee, H G 1995. Chemistry of peptides associated with MHC class I and class II molecules Curr. Opin Immunol 7:85.
26. Hammer J., Bono, E , Gallazzi, F., Belunis, C., Nagy, Z. and Sinigaglia, F 1994. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning J Exp Med 180.2353
27. Hammer, J , Gallazzi, F., Bono, E , Karr, R. W., Guenot, J . Valsasnini, P., Nagy, Z A. and Sinigaglia, F 1995. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association J Exp. Med 181 1847.
28. Kinouchi, R , Kobayasi, H., Sato, K., Kimura, S. and Katagiri, M. 1994 Peptide motifs of HLA-DR4/DR53 (DRB1*0405/DRB*0101) molecules Immunogenetics 40:376
29. Marshall, K W., Liu, A. F , Canales, J., Perahia, B., Jorgensen, B., Gantzos, R. D., Aguilar, B , Devaux, B. and Rothbard, J. B. 1994. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands J Immunol 152:4946.
30. O'Sullivan, D , Arrhenius, T., Sidney, J . Del Guercio, M. F , Albertson, M., Wall, M., Oseroff, C., Southwood, S , Colón S M , Gaeta F C. A. and Sette, A 1991. On the interaction of promiscuous antigenic peptides with different DR alleles J. Immunol. 147 2663
31. Hammer, J., Takacs, B and Sinigaglia, F. 1992. identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J. Exp. Med. 176:1007.
32. Chicz, R. M., Urban, R. G., Lane, W. S , Gorga, J. C., Stern, L. J., Vignali, D. A. A. and Strominger J L. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764.